OBJECTIVE: The purpose of this study was to determine whether a variation in the transcription factor 7-like 2 (TCF7L2) gene, which influences diabetes risk, is associated with incidence of cancers. RESEARCH DESIGN AND METHODS: We related diabetes and TCF7L2 variation with occurrence of several common cancers in a prospective cohort study of 13,117 middle-aged adults initially free of cancer in 1987-1989. We assessed five single nucleotide polymorphisms (SNPs) in TCF7L2 including the putative SNP (rs7903146) for diabetes. We identified incident cancers through 2000 via cancer registries, supplemented by hospital records. RESULTS: Diabetes was associated marginally inversely with incidence of prostate cancer but not with incidence of colorectal, colon, lung, or breast cancer. The T allele of rs7903146 (frequency 30%) was associated with increased risk of colorectal cancer and, more specifically, colon cancer, with adjusted hazard ratios (95% CI) of 1.0 for CC, 1.25 (0.85-1.83) for CT, and 2.15 (1.27-3.64) for TT genotypes (P(trend) = 0.009). TCF7L2 variation also was associated with lung cancer incidence in whites but not blacks, but residual confounding by smoking may be present. CONCLUSIONS: Subjects who were initially cancer-free and carrying certain genetic variants of TCF7L2, most notably the T allele of rs7903146, have an increased risk of colon cancer. This association appears to be an independent gene effect not explained by diabetes. Because the T allele of rs7903146 is common, if a causal link is established, this variant could account for a sizable proportion ( approximately 17% here) of cases of colon cancer in the general population.
OBJECTIVE: The purpose of this study was to determine whether a variation in the transcription factor 7-like 2 (TCF7L2) gene, which influences diabetes risk, is associated with incidence of cancers. RESEARCH DESIGN AND METHODS: We related diabetes and TCF7L2 variation with occurrence of several common cancers in a prospective cohort study of 13,117 middle-aged adults initially free of cancer in 1987-1989. We assessed five single nucleotide polymorphisms (SNPs) in TCF7L2 including the putative SNP (rs7903146) for diabetes. We identified incident cancers through 2000 via cancer registries, supplemented by hospital records. RESULTS:Diabetes was associated marginally inversely with incidence of prostate cancer but not with incidence of colorectal, colon, lung, or breast cancer. The T allele of rs7903146 (frequency 30%) was associated with increased risk of colorectal cancer and, more specifically, colon cancer, with adjusted hazard ratios (95% CI) of 1.0 for CC, 1.25 (0.85-1.83) for CT, and 2.15 (1.27-3.64) for TT genotypes (P(trend) = 0.009). TCF7L2 variation also was associated with lung cancer incidence in whites but not blacks, but residual confounding by smoking may be present. CONCLUSIONS: Subjects who were initially cancer-free and carrying certain genetic variants of TCF7L2, most notably the T allele of rs7903146, have an increased risk of colon cancer. This association appears to be an independent gene effect not explained by diabetes. Because the T allele of rs7903146 is common, if a causal link is established, this variant could account for a sizable proportion ( approximately 17% here) of cases of colon cancer in the general population.
Authors: Marc van de Wetering; Elena Sancho; Cornelis Verweij; Wim de Lau; Irma Oving; Adam Hurlstone; Karin van der Horn; Eduard Batlle; Damien Coudreuse; Anna Pavlina Haramis; Menno Tjon-Pon-Fong; Petra Moerer; Maaike van den Born; Gwen Soete; Steven Pals; Martin Eilers; Rene Medema; Hans Clevers Journal: Cell Date: 2002-10-18 Impact factor: 41.582
Authors: K E Anderson; E Anderson; P J Mink; C P Hong; L H Kushi; T A Sellers; D Lazovich; A R Folsom Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-06 Impact factor: 4.254
Authors: David E Laaksonen; Leo Niskanen; Kari Punnonen; Kristiina Nyyssönen; Tomi-Pekka Tuomainen; Riitta Salonen; Rainer Rauramaa; Jukka T Salonen Journal: Eur J Endocrinol Date: 2003-12 Impact factor: 6.664
Authors: Iona Cheng; Christian P Caberto; Annette Lum-Jones; Ann Seifried; Lynne R Wilkens; Fredrick R Schumacher; Kristine R Monroe; Unhee Lim; Maarit Tiirikainen; Laurence N Kolonel; Brian E Henderson; Daniel O Stram; Christopher A Haiman; Loïc Le Marchand Journal: Gut Date: 2011-05-20 Impact factor: 23.059
Authors: Ellen L Goode; Csilla Szabo; Ludmila Prokunina-Olsson; Robert A Vierkant; Zachary S Fredericksen; Francis S Collins; Kristin L White; Michele Schmidt; Brooke L Fridley; Fergus J Couch Journal: BMC Cancer Date: 2009-09-04 Impact factor: 4.430
Authors: Konstantinos K Tsilidis; Kathy J Helzlsouer; Michael W Smith; Victoriya Grinberg; Judith Hoffman-Bolton; Sandra L Clipp; Kala Visvanathan; Elizabeth A Platz Journal: Cancer Causes Control Date: 2009-11 Impact factor: 2.506
Authors: André Gustavo P Sousa; Guilherme F Marquezine; Pedro A Lemos; Eulogio Martinez; Neuza Lopes; Whady A Hueb; José E Krieger; Alexandre C Pereira Journal: PLoS One Date: 2009-11-17 Impact factor: 3.240